Novartis AG
NOVNSIX

Novartis AG

Pharmaceuticals · Switzerland

← Back to markets

Track Novartis AG

Add to watchlist

Share price

Live market data
CHF 123.74 +22.46 (+22.18%)2025-08-262026-08-27
CHF 132.54CHF 124.94CHF 117.34CHF 109.74CHF 102.14CHF 94.542025-08-262026-08-27
Next earningsTue, 27 Oct 2026Earnings calendar →

About Novartis AG

Novartis AG is one of the world’s largest pharmaceutical companies, focused on discovering, developing, manufacturing, and commercialising innovative medicines. Headquartered in Switzerland, the company operates across major therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, immunology, and neuroscience, serving patients, healthcare providers, hospitals, and health systems across global markets.

Novartis’ strength comes from its research base, global commercial scale, specialist medicine portfolio, and focus on high-value areas of unmet medical need. The company is increasingly positioned as a pure-play innovative medicines business, with technology platforms including chemistry, biotherapeutics, radioligand therapy, xRNA, and gene and cell therapy. This gives Novartis a defensive healthcare profile with long-term exposure to medical innovation, ageing populations, chronic disease treatment, and next-generation pharmaceutical technologies.

Need deeper analysis on Novartis AG? ET&A Professional includes full company notes, valuations and models — or commission bespoke research.